We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$13B
AUM Growth
+$1.56B
Cap. Flow
+$847M
Cap. Flow %
6.54%
Top 10 Hldgs %
18.23%
Holding
2,527
New
188
Increased
1,360
Reduced
792
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 6.93%
2 Financials 4.91%
3 Healthcare 4.18%
4 Consumer Discretionary 3.53%
5 Communication Services 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIO icon
801
Rio Tinto
RIO
$160B
$1.99M 0.02%
33,502
+6,624
+25% +$359K
ARI
802
Apollo Commercial Real Estate
ARI
$886M
$1.98M 0.02%
108,499
+14,968
+16% +$276K
RCL icon
803
Royal Caribbean
RCL
$82.9B
$1.98M 0.02%
14,835
+912
+7% +$106K
PNQI icon
804
Invesco NASDAQ Internet ETF
PNQI
$544M
$1.98M 0.02%
69,935
-520
-0.7% -$14K
PNW icon
805
Pinnacle West Capital
PNW
$12.2B
$1.96M 0.02%
21,823
+2,322
+12% +$210K
CEF icon
806
Sprott Physical Gold and Silver Trust
CEF
$8.17B
$1.95M 0.02%
132,956
-56,535
-30% -$810K
FXO icon
807
First Trust Financials AlphaDEX Fund
FXO
$1.15B
$1.95M 0.02%
58,061
-5,833
-9% -$190K
EBAY icon
808
eBay
EBAY
$46.5B
$1.94M 0.02%
53,727
+299
+0.6% +$10.8K
CSQ icon
809
Calamos Strategic Total Return Fund
CSQ
$3.37B
$1.93M 0.01%
142,078
-71,937
-34% -$943K
BMVP icon
810
Invesco Bloomberg MVP Multi-factor ETF
BMVP
$107M
$1.93M 0.01%
58,557
-36
-0.1% -$1.16K
HCA icon
811
HCA Healthcare
HCA
$89.1B
$1.92M 0.01%
12,998
-92
-0.7% -$12.4K
LVHD icon
812
Franklin US Low Volatility High Dividend Index ETF
LVHD
$630M
$1.91M 0.01%
56,061
+23,761
+74% +$797K
DIAL icon
813
Columbia Diversified Fixed Income Allocation ETF
DIAL
$388M
$1.91M 0.01%
91,629
+44,582
+95% +$926K
RGLD icon
814
Royal Gold
RGLD
$19.1B
$1.9M 0.01%
15,575
-2,802
-15% -$331K
PIE icon
815
Invesco Dorsey Wright Emerging Markets Momentum ETF
PIE
$250M
$1.9M 0.01%
99,316
+6,186
+7% +$115K
RZV icon
816
Invesco S&P SmallCap 600 Pure Value ETF
RZV
$307M
$1.9M 0.01%
+27,217
New +$1.81M
MOS icon
817
The Mosaic Company
MOS
$6.92B
$1.9M 0.01%
87,703
-11,573
-12% -$229K
CRUS icon
818
Cirrus Logic
CRUS
$6.08B
$1.9M 0.01%
+23,009
New +$1.56M
FDT icon
819
First Trust Developed Markets ex-US AlphaDEX Fund
FDT
$1.33B
$1.89M 0.01%
34,027
-8,890
-21% -$481K
WDC icon
820
Western Digital
WDC
$168B
$1.89M 0.01%
39,428
-415
-1% -$17.3K
BIIB icon
821
Biogen
BIIB
$31.1B
$1.89M 0.01%
6,372
+1,454
+30% +$403K
LEG icon
822
Leggett & Platt
LEG
$1.32B
$1.88M 0.01%
37,017
-11,424
-24% -$560K
VRTX icon
823
Vertex Pharmaceuticals
VRTX
$131B
$1.87M 0.01%
8,553
+1,175
+16% +$238K
LIT icon
824
Global X Lithium & Battery Tech ETF
LIT
$1.6B
$1.87M 0.01%
68,420
+13,540
+25% +$346K
DPLO
825
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$1.86M 0.01%
466,082
-340,737
-42% -$1.6M

Similar funds

Cambridge Investment Research Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Cambridge Investment Research Advisors held 2,527 positions worth $13B, up 14% from $11.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors deployed $847M of net new capital in Q4 2019, opening 188 new positions and adding to 1,360 existing holdings. Its largest new stake was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 76,384 shares worth $5.5M.

By sector, the portfolio is most concentrated in Technology at 6.9% of assets, up from 6.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $23.2M trimmed.

  • Cambridge Investment Research Advisors's largest Q4 2019 buy was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 76,384 shares worth $5.5M.
  • Cambridge Investment Research Advisors added most to Vanguard Morningstar Total Stock Market ETF in Q4 2019, an estimated $38.2M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2019 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $23.2M.
  • Cambridge Investment Research Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $13.9M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $13B portfolio in Q4 2019.
  • Cambridge Investment Research Advisors opened 188 new positions and closed 124 in Q4 2019.
  • Cambridge Investment Research Advisors's portfolio value rose 14% quarter-over-quarter to $13B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2019, filed 4 Feb 2020.